G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 94 filers reported holding G1 THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $208,000 | +51.8% | 20,418 | +100.0% | 0.00% | – |
Q3 2021 | $137,000 | -22.6% | 10,209 | 0.0% | 0.00% | – |
Q2 2021 | $177,000 | -75.6% | 10,209 | -66.1% | 0.00% | -100.0% |
Q1 2021 | $724,000 | +39.5% | 30,081 | +4.3% | 0.00% | 0.0% |
Q4 2020 | $519,000 | +55.9% | 28,842 | 0.0% | 0.00% | – |
Q3 2020 | $333,000 | -52.4% | 28,842 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $700,000 | +135.7% | 28,842 | +7.1% | 0.00% | 0.0% |
Q1 2020 | $297,000 | -68.6% | 26,942 | -24.6% | 0.00% | 0.0% |
Q4 2019 | $945,000 | +0.3% | 35,742 | -13.5% | 0.00% | 0.0% |
Q3 2019 | $942,000 | -6.7% | 41,342 | +25.5% | 0.00% | -50.0% |
Q2 2019 | $1,010,000 | +41.9% | 32,950 | -23.2% | 0.00% | +100.0% |
Q1 2019 | $712,000 | -12.5% | 42,891 | +0.9% | 0.00% | 0.0% |
Q4 2018 | $814,000 | -66.7% | 42,491 | -9.1% | 0.00% | -75.0% |
Q3 2018 | $2,444,000 | +72.1% | 46,743 | +43.1% | 0.00% | +100.0% |
Q2 2018 | $1,420,000 | +48.4% | 32,668 | +26.4% | 0.00% | +100.0% |
Q1 2018 | $957,000 | – | 25,836 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 856,798 | $6,512,000 | 1.75% |
CHI Advisors LLC | 488,635 | $3,714,000 | 1.58% |
Pinz Capital Management, LP | 186,515 | $1,418,000 | 0.88% |
Lombard Odier Asset Management (Switzerland) SA | 542,183 | $4,121,000 | 0.32% |
Rhenman & Partners Asset Management AB | 316,137 | $2,403,000 | 0.24% |
Birchview Capital, LP | 40,000 | $304,000 | 0.22% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 160,000 | $1,216,000 | 0.18% |
Tekla Capital Management LLC | 423,869 | $3,221,000 | 0.11% |
Golden Green, Inc. | 12,152 | $92,000 | 0.08% |
Virtus ETF Advisers LLC | 15,188 | $115,000 | 0.05% |